← Eichor
Study identifier: NCT03655015 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer

Condition: Lung Neoplasm  ·  Sponsor: The University of Texas Health Science Center at San Antonio

PhaseN/A
Planned participants150
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Create a living biobank of PDOs from Stage I-III lung cancer patients.

This description comes directly from the study's public registry record.

Talk to the study team

Josephine Taverna, MD  ·  210-450-8234  ·  tavernaj@uthscsa.edu

Always discuss trial participation with your own doctor first.

Locations (1)

UT Health San Antonio, M.D. Anderson Cancer CenterSan Antonio, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03655015